Literature DB >> 30423041

Antimicrobial Stewardship in China: Systems, Actions and Future Strategies.

Yonghong Xiao1.   

Abstract

Antimicrobial resistance (AMR) has become a serious global public health crisis, and AMR control has consequently become a priority in all countries. Specifically, the incidence of various common multidrug-resistant bacteria is high, and there are multiple problems concerning the irrational use of antimicrobial drugs. In the past decade, China has established a relatively comprehensive management system and technical support framework for antimicrobial stewardship, including regulations, guidelines, networks for the surveillance of AMR and antimicrobial consumption, and professional personnel training. In addition, the Ministry of Health has carried out a special campaign to promote the proper clinical use of antibiotics in medical institutions, which significantly improved outcomes. The use of antibacterial drugs without indication and the consumption of antibiotics have been significantly reduced. In consideration of the factors that contribute to AMR, the structure of the healthcare system in China, and the need for long-term sustaining efforts to control AMR, the strategy of "two steps and two hands" must be implemented to contain AMR. The first step is to generally promote the rational use of antimicrobial agents in order to promptly curb the rising momentum of resistance with high pressure from the government. The second step requires sustainable professional work with the implementation of precise AMR control. The "first hand" refers to the government-oriented active establishment and optimization of the system and infrastructure of rational antibiotic use and AMR control. The "second hand" refers to the cultivation of professional teams to ensure the establishment and development of sustainable processes in AMR control.

Mesh:

Substances:

Year:  2018        PMID: 30423041     DOI: 10.1093/cid/ciy641

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study.

Authors:  Haishaerjiang Wushouer; Zhenhuan Luo; Xiaodong Guan; Luwen Shi
Journal:  Int J Health Policy Manag       Date:  2022-02-01

Review 2.  Quality of primary health care in China: challenges and recommendations.

Authors:  Xi Li; Harlan M Krumholz; Winnie Yip; Kar Keung Cheng; Jan De Maeseneer; Qingyue Meng; Elias Mossialos; Chuang Li; Jiapeng Lu; Meng Su; Qiuli Zhang; Dong Roman Xu; Liming Li; Sharon-Lise T Normand; Richard Peto; Jing Li; Zengwu Wang; Hongbing Yan; Runlin Gao; Somsak Chunharas; Xin Gao; Raniero Guerra; Huijie Ji; Yang Ke; Zhigang Pan; Xianping Wu; Shuiyuan Xiao; Xinying Xie; Yujuan Zhang; Jun Zhu; Shanzhu Zhu; Shengshou Hu
Journal:  Lancet       Date:  2020-06-06       Impact factor: 79.321

3.  Assessment of knowledge and attitude trends towards antimicrobial resistance (AMR) among the community members, pharmacists/pharmacy owners and physicians in district Sialkot, Pakistan.

Authors:  Hassan Waseem; Jafar Ali; Fiza Sarwar; Aroosa Khan; Hamza Saleem Ur Rehman; Mishal Choudri; Nooh Arif; Muhammad Subhan; Aansa Rukya Saleem; Asif Jamal; Muhammad Ishtiaq Ali
Journal:  Antimicrob Resist Infect Control       Date:  2019-04-24       Impact factor: 4.887

4.  Using Weibo and WeChat social media channels to assess public awareness and practices related to antimicrobial resistance, China, 2019.

Authors:  Lei Wang; Sujian Situ; Jeanette J Rainey; Bin He; Xiaoge Su; Ronald L Moolenaar; Ying Cui
Journal:  BMC Public Health       Date:  2021-05-14       Impact factor: 3.295

5.  Impact of the Expert Consensus on Carbapenem Consumption Trends and Patterns in Public Healthcare Institutes: An Interrupted Time Series Analysis, 2017-2020.

Authors:  Dan Ye; Caijun Yang; Wenjing Ji; Jie Zheng; Jingyi Zhang; Runqing Xue; Jianli Gu; Minchun Chen; Kangkang Yan; Yongzhong Liu
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

6.  Blood bacterial resistant investigation collaborative system (BRICS) report: a national surveillance in China from 2014 to 2019.

Authors:  Yunbo Chen; Jinru Ji; Chaoqun Ying; Zhiying Liu; Qing Yang; Haishen Kong; Yonghong Xiao
Journal:  Antimicrob Resist Infect Control       Date:  2022-01-24       Impact factor: 4.887

7.  Cluster randomised controlled trial to assess a tailored intervention to reduce antibiotic prescribing in rural China: study protocol.

Authors:  Wenjuan Cong; Jing Chai; Christie Cabral; DeBin Wang; Linhai Zhao; Lucy Yardley; Guiqing Lily Yao; Tingting Zhang; Jing Cheng; XingRong Shen; Rong Liu; Paul Little; Beth Stuart; Xiaowen Hu; Ye-Huan Sun; Isabel Oliver; Bo Zheng; Helen Lambert
Journal:  BMJ Open       Date:  2022-01-03       Impact factor: 2.692

8.  Antibiotic Sales in Primary Care in Hubei Province, China: An Analysis of 2012-2017 Procurement Records.

Authors:  Xinping Zhang; Youwen Cui; Chaojie Liu; Keyuan Zuo; Yuqing Tang
Journal:  Int J Environ Res Public Health       Date:  2019-09-12       Impact factor: 3.390

9.  Validation of an algorithm to evaluate the appropriateness of outpatient antibiotic prescribing using big data of Chinese diagnosis text.

Authors:  Houyu Zhao; Jiaming Bian; Li Wei; Liuyi Li; Yingqiu Ying; Zeyu Zhang; Xiaoying Yao; Lin Zhuo; Bin Cao; Mei Zhang; Siyan Zhan
Journal:  BMJ Open       Date:  2020-03-19       Impact factor: 2.692

10.  Analysis of Antibiotic Use Patterns and Trends Based on Procurement Data of Healthcare Institutions in Shaanxi Province, Western China, 2015-2018.

Authors:  Sen Xu; Shengfang Yuan; John Alimamy Kabba; Chen Chen; Wenchen Liu; Jie Chang; Yu Fang
Journal:  Int J Environ Res Public Health       Date:  2020-10-16       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.